[1]冯乐*,李妍,秦敏春.乌鲁木齐地区365例亚临床甲减孕妇妊娠结局的影响研究[J].中国计划生育和妇产科,2018,(8):79-81.
 FENG Le*,Li Yan,QIN Min-chun.Effect of subclinical hypothyroidism on 365 cases of maternal pregnancy in Urumqi[J].Chinese Journal of Family Planning & Gynecotokology,2018,(8):79-81.
点击复制

乌鲁木齐地区365例亚临床甲减孕妇妊娠结局的影响研究
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2018年8期
页码:
79-81
栏目:
论著与临床
出版日期:
2018-08-25

文章信息/Info

Title:
Effect of subclinical hypothyroidism on 365 cases of maternal pregnancy in Urumqi
作者:
冯乐* 李妍秦敏春
乌鲁木齐市妇幼保健院检验科
Author(s):
FENG Le* Li Yan QIN Min-chun
Department of Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi Xinjiang 830000,P.R.China
关键词:
亚临床甲状腺功能减退妊娠左旋甲状腺素
Keywords:
subclinical hypothyroidism pregnancy levothyroxine
分类号:
R 714.256
摘要:
目的探讨亚临床甲状腺功能减退(亚临床甲减)对乌鲁木齐地区孕妇妊娠结局的影响,并观察左旋甲状腺素片干预后妊娠结局的变化。方法回顾性分析2016年1月至2017年4月在乌鲁木齐市妇幼保健院产检的健康孕妇6 384例的临床资料,其中甲状腺功能正常孕妇6 019例(A组),亚临床甲减孕妇365例,再根据是否使用左旋甲状腺素片干预将365例亚临床甲减孕妇分为亚临床甲减对照组(B组,183例)和左旋甲状腺素片干预观察组(C组,182例)。比较3组的妊娠结局和新生儿情况。结果3组间妊娠期高血压疾病、羊水异常发生率无显著性差异(P>005)。妊娠期糖尿病、早产、剖宫产、产后出血、胎盘早剥在A组的发生率为213 %、724 %、2102 %、359 %、123 %,在C组为330 %、824 %、2363 %、440 %、165 %,A、C组间上述指标比较差异无统计学意义(P>005),但均低于B组的929 %、1311 %、3880 %、874 %、383 %(P<005)。3组间低体重儿、巨大儿发生率比较,差异无统计学意义(P>005)。胎儿宫内窘迫、Apgar评分0~3分、Apgar评分4~7分的比率A组为312 %、045 %、128 %,C组为384 %、055 %、165 %,A、C组间上述指标比较差异无统计学意义(P>005),但均低于B组的601 %、328 %、492 %(P<005)。结论 妊娠期亚临床甲减会对孕产妇和胎儿带来危害,积极的干预可以显著降低不良妊娠结局的发生率。
Abstract:
ObjectiveTo explore the effect of subclinical hypothyroidism on pregnancy and the intervention of thyroxine. MethodsThe clinical data of 6 384 cases of healthy pregnant women from January 2016 to April 2017 in Urumqi Maternal and Child Health Care Hospital were retrospectively analyzed.Among them, 6 019 pregnant women were with normal thyroid function(group A) and 365 pregnant women were with subclinical hypothyroidism. According to whether used levothyroxine tablets, 365 cases of subclinical hypothyroidism were divided into subclinical hypothyroidism control group (group B,183 cases) and levothyroxine tablets intervention group (group C,182 cases).The pregnancy outcomes and neonatal conditions were compared between the three groups. ResultsThere was no significant difference of the incidence of hypertensive disorder complicating pregnancy and amniotic fluid abnormalities between group A, group B and group C(P>005). The incidence of gestational diabetes, premature birth, cesarean section, postpartum hemorrhage and placental abruption in group A were 213 %, 724 %, 2102 %, 359 % and 123 %, and 330 %, 824 %, 2363 %, 440 % and 165 % in group C, respectively. Which were all lower than that of 929 %, 1311 %, 3880 %, 874 % and 383 % in group B(P<005). There was no significant difference of the incidence of low birth weight infants and macrosomia between the 3 groups(P>005). The rates of fetal distress, Apgar 0~3 score and Apgar 4~7 score in group A were 312 %, 045 % and 128 %, and 384 %, 055 %, and 165 % in group C, respectively. Which were all lower than that of 601 %, 328 %, and 492 % in group B(P<005). ConclusionSubclinical hypothyroidism in pregnancy can be harmful to pregnant women and fetuses. Active intervention can significantly reduce the incidence of adverse pregnancy outcomes.

参考文献/References:

[1]GREENHILL C.Thyroid function: Thyroid hypofunction in pregnancy [J].Nature Reviews Endocrinology,2017,13(10): 562. [2]吴洪秋,黄坚尧,黄武炎,等孕早中期孕妇轻度甲状腺功能减退症的影响因素及与不良妊娠结果的关系研究 [J]国际检验医学杂志,2017,38(14):1977-1979 [3]HADDOW J E, PALOMAKI G E. Subclinical hypothyroidism or hypothyroxinemia in pregnancy [J]. New England Journal of Medicine, 2017, 377(7): 700-701. [4]中华医学会内分泌学分会中华医学会围产医学分会.妊娠和产后甲状腺疾病诊治指南 [J]中华内分泌代谢杂志,2012,28(5):354-371 [5]KOREVAAR T I, MEDICI M, VISSER T J, et al. Thyroid disease in pregnancy: new insights in diagnosis and clinical management [J]. Nature Reviews Endocrinology, 2017, 13(10): 610-622. [6]晋柏,袁庆新,陈茜,等诊断标准,孕妇年龄和甲状腺过氧化物酶抗体水平对妊娠后半期甲状腺疾病发病率的影响 [J]中华围产医学杂志,2016,19(12):914-919 [7]朱燕飞,施美华,吕美丹,等亚临床甲状腺功能异常与妊娠结局的关系 [J]浙江实用医学,2015,20(5):323-324, 331 [8]王蕴慧,张培,赵会丹,等甲状腺功能异常与妊娠结局的关系 [J]中华内分泌代谢杂志,2014,30(12):1058-1062 [9]ZHANG Yong, DAI Xiaobei, YANG Shuai, et al. Maternal low thyroxin levels are associated with adverse pregnancy outcomes in a Chinese population [J]. PLOS One, 2017, 12(5): e0178100. [10]董小跃,许张晔左旋甲状腺素片干预后对甲状腺功能正常TPOAb阳性孕妇妊娠结局的影响 [J]数理医药学杂志,2017,30(8):1192-1194 [11]REID S M, MIDDLETON P, COSSICH M C, et al. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy [J]. The Cochrane Database of Systematic Reviews, 2013, 21(5): CD007752. [12]SPENCER L, BUBNER T, BAIN E, et al. Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health [J]. The Cochrane Database of Systematic Reviews, 2015, 21(9): CD011263.

相似文献/References:

[1]阚滨,肖美霞.妊娠合并血小板减少症65例临床分析[J].中国计划生育和妇产科,2009,(05):0.
 KAN Bin,XIAO Mei-xia The department of gynaecology and obstetrics,Shengli hospital of Rugao city,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(8):0.
[2]廖治,杨业洲.多发性硬化和妊娠[J].中国计划生育和妇产科,2009,(05):0.
[3]周萍,李秀美,江彩虹,等.妊娠合并卵巢肿瘤98例临床分析[J].中国计划生育和妇产科,2010,(02):0.
[4]莫丽芳.剖宫产手术中行子宫肌瘤剔除术体会[J].中国计划生育和妇产科,2010,(04):0.
 MO Li-fang Shilong Peoples hospital of Dongguan city,Dongguan Guangdong,China.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(8):0.
[5]何博.妊娠合并先天性心脏病的诊治研究进展[J].中国计划生育和妇产科,2010,(04):0.
[6]韩雪玲.妊娠期合并尖锐湿疣200例治疗方法比较[J].中国计划生育和妇产科,2011,(04):0.
 HAN Xue-ling.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[7]张帆.孕妇哮喘及其安全监护[J].中国计划生育和妇产科,2011,(05):0.
 ZHANG Fan Chinese Medical Doctor Association in Beijing,Beijing 000,P.R.China.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[8]朱林,车兰芬.不同剂量米非司酮用于妊娠10~14周流产的临床观察[J].中国计划生育和妇产科,2012,(04):0.
 ZHU Lin,CHE Lan-fen.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(8):0.
[9]韦冰,车小群,许丽华,等.血清CA125在评估卵巢子宫内膜异位囊肿的分期及术后妊娠情况中的价值[J].中国计划生育和妇产科,2012,(06):0.
 WEI Bing*,CHE Xiao-qun,XU Li-hua Center of reproductive medicine,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(8):0.
[10]孙国娟.不同剂量米非司酮用于妊娠8~10周流产的临床观察[J].中国计划生育和妇产科,2013,(05):0.
 SUN Guo-juan,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(8):0.

更新日期/Last Update: 2018-08-25